BridgeBio Pharma, Inc.
BBIONASDAQHealthcare● Active
$67.37
$-0.24(-0.35%)
Market Cap$13.2B
P/E Ratio—
52W High$84.94
52W Low$38.575
BridgeBio Pharma, Inc.（BBIO）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BBIO · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.59B | $0.68B | $0.43B | $0.47B | $0.84B |
| Net Receivables | $0.14B | $0.00B | $0.00B | $0.02B | $0.02B |
| Inventory | $0.03B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.75B | $0.72B | $0.48B | $0.55B | $0.89B |
| PP&E Net | $0.01B | $0.01B | $0.02B | $0.03B | $0.05B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.03B | $0.02B | $0.03B | $0.03B | $0.04B |
| Total Assets | $0.94B | $0.92B | $0.55B | $0.62B | $1.01B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.04B | $0.01B | $0.01B | $0.01B | $0.01B |
| Total Current Liabilities | $0.29B | $0.15B | $0.14B | $0.12B | $0.14B |
| Long-Term Debt | $2.71B | $1.72B | $1.73B | $1.71B | $1.70B |
| Total Liabilities | $3.01B | $2.38B | $1.89B | $1.87B | $1.88B |
| Stockholders Equity | |||||
| Retained Earnings | ($3.82B) | ($3.10B) | ($2.56B) | ($1.92B) | ($1.44B) |
| Total Stockholders Equity | ($2.08B) | ($1.47B) | ($1.35B) | ($1.25B) | ($0.87B) |
| Total Liab & Equity(computed) | $0.94B | $0.91B | $0.53B | $0.61B | $1.01B |
| Debt Summary | |||||
| Total Debt | $2.73B | $1.73B | $1.74B | $1.72B | $1.73B |
| Net Debt | $2.16B | $1.05B | $1.36B | $1.35B | $1.33B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解BridgeBio Pharma, Inc.
关于BridgeBio Pharma, Inc.（BBIO）资产负债表
BridgeBio Pharma, Inc.总资产$0.94B，现金及短期投资$0.59B，总负债$3.01B，总债务$2.73B，股东权益($2.08B)。
常见问题
BBIO · 4 问BridgeBio Pharma, Inc.总债务$2.73B，净债务$2.16B。
BBIO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10